Vestiage, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VEST research report →
Companywww.vestiageinc.com
Vestiage, Inc. , a healthy aging company, creates, acquires, markets, and distributes science-based nutraceuticals and cosmeceuticals. It offers testosterone support, growth hormone support, antioxidant and inflammation response, DHEA support, heart health, brain support, prostate health, and vitamin and mineral products for men under the RegiMEN brand name.
- CEO
- Raymond Fu
- IPO
- 2013
- Employees
- 3
- HQ
- Admiralty, CA, US
Price Chart
Valuation
- Market Cap
- $5.02M
- P/E
- -61.48
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -61.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 41.14%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-79,336 · -50.61%
- EPS
- $-0.17 · -169900.00%
- Op Income
- $-79,336
- FCF YoY
- -71.47%
Performance & Tape
- 52W High
- $80.00
- 52W Low
- $0.01
- 50D MA
- $10.95
- 200D MA
- $21.31
- Beta
- -1.24
- Avg Volume
- 1.45K
Get TickerSpark's AI analysis on VEST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VEST Coverage
We haven't published any research on VEST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VEST Report →